Skip to main content
. 2019 Jul 24;9:10716. doi: 10.1038/s41598-019-47009-7

Figure 3.

Figure 3

Promoter-based cell-type targeting. (A) Diagram of cotransfection using the ubiquitous CAG promoter to drive HyPBase and integrating palmTagRFP reporter. (B) As in (A), using the mouse aMHC promoter to drive HyPBase. (C) Comparison of plasmid expression 16 hrs. and 160 hrs. post transfection. (D) Diagram of dissociation protocol. (E) Comparison of MF20+ (green), palmTagRFP+ cells between CAG-HyPBase and aMHC-HyPBase transfected cells, asterisks indicate non-myocytes (MF20-). Scalebar = 100 um (F) Quantification of the percentage of myocytes following dissociation and culture of CAG-HyPBase and aMHC-HyPBase transfected hearts (n = 5547 cells, 3 biological replicates per group). (G) Quantification of the percentage of palmTagRFP positive cells that were myocytes following dissociation and culture of CAG-HyPBase and aMHC-HyPBase transfected hearts (n = 387 cells, 3 biological replicates per group).